Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-03-12
DOI
10.1002/med.21496
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lymphedema: Pathogenesis and Novel Therapies
- (2018) Joseph H. Dayan et al. Annual Review of Medicine
- Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation
- (2017) David Miles et al. EUROPEAN JOURNAL OF CANCER
- Lymphangiogenesis: fuel, smoke, or extinguisher of inflammation’s fire?
- (2017) Gabriella R Abouelkheir et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Inflammatory Manifestations of Lymphedema
- (2017) Catherine Ly et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases
- (2017) Melissa García-Caballero et al. Journal of Hematology & Oncology
- Novel role of immature myeloid cells in formation of new lymphatic vessels associated with inflammation and tumors
- (2017) Sophia Ran et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance
- (2017) ShaghayeghHaghjooy Javanmard et al. Journal of Research in Medical Sciences
- Tumor angiogenesis revisited: Regulators and clinical implications
- (2017) Roberto Ronca et al. MEDICINAL RESEARCH REVIEWS
- Fibroblast growth factor-2 drives and maintains progressive corneal neovascularization following HSV-1 infection
- (2017) H R Gurung et al. Mucosal Immunology
- Therapeutic targeting of the angiopoietin–TIE pathway
- (2017) Pipsa Saharinen et al. NATURE REVIEWS DRUG DISCOVERY
- Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma
- (2017) Manuel Fankhauser et al. Science Translational Medicine
- Cervical cancer cell–derived angiopoietins promote tumor progression
- (2017) Ping Yang et al. TUMOR BIOLOGY
- The “inherent vice” in the anti-angiogenic theory may cause the highly metastatic cancer to spread more aggressively
- (2017) Denian Wang et al. Scientific Reports
- Nanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers
- (2017) Roghaye Arezumand et al. Frontiers in Immunology
- Distinct transcriptional responses of lymphatic endothelial cells to VEGFR-3 and VEGFR-2 stimulation
- (2017) Lothar C. Dieterich et al. Scientific Data
- Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies – A review
- (2017) Ahmed M. Al-Abd et al. Journal of Advanced Research
- Transient Ingrowth of Lymphatic Vessels into the Physiologically Avascular Cornea Regulates Corneal Edema and Transparency
- (2017) Deniz Hos et al. Scientific Reports
- Roles of signaling and transcriptional networks in pathological lymphangiogenesis
- (2016) Yasuhiro Yoshimatsu et al. ADVANCED DRUG DELIVERY REVIEWS
- Tumor lymphangiogenesis and new drug development
- (2016) Lothar C. Dieterich et al. ADVANCED DRUG DELIVERY REVIEWS
- Blood capillary rarefaction and lymphatic capillary neoangiogenesis are key contributors to renal allograft fibrosis in an ACE inhibition rat model
- (2016) Péter Hamar et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Lymphangiogenesis in rat asthma model
- (2016) Aigul Moldobaeva et al. ANGIOGENESIS
- A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group study
- (2016) O. Trédan et al. ANNALS OF ONCOLOGY
- Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model
- (2016) Shotaro Maehana et al. BIOMEDICINE & PHARMACOTHERAPY
- SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial
- (2016) Christoph Rochlitz et al. BMC CANCER
- Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway
- (2016) M García-Caballero et al. BRITISH JOURNAL OF PHARMACOLOGY
- Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer
- (2016) Muhammad Wasif Saif et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model
- (2016) Jesse Gore et al. CANCER LETTERS
- The potential role of perivascular lymphatic vessels in preservation of kidney allograft function
- (2016) Akihiro Tsuchimoto et al. Clinical and Experimental Nephrology
- Angiogenesis inhibitors for patients with ovarian cancer: a meta-analysis of 12 randomized controlled trials
- (2016) Xuyuan Li et al. CURRENT MEDICAL RESEARCH AND OPINION
- Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions
- (2016) Zhexuan Lin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Endothelial activation, lymphangiogenesis, and humoral rejection of kidney transplants
- (2016) Sharon Phillips et al. HUMAN PATHOLOGY
- Cornea lymphatics drive the CD8+ T-cell response to herpes simplex virus-1
- (2016) Hem R Gurung et al. IMMUNOLOGY AND CELL BIOLOGY
- Association between levels of anti-angiogenic isoform of vascular endothelial growth factor A and pulmonary hypertension
- (2016) Satoshi Suzuki et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D
- (2016) Natalia Davydova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD
- (2016) Hung M. Bui et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor–Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)
- (2016) Maura N. Dickler et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of fatty acid β-oxidation in lymphangiogenesis
- (2016) Brian W. Wong et al. NATURE
- Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions
- (2016) Jessica F. Yang et al. SURVEY OF OPHTHALMOLOGY
- Lymph vessels: the forgotten second circulation in health and disease
- (2016) Lukasz A. Adamczyk et al. VIRCHOWS ARCHIV
- Fucoidan inhibits lymphangiogenesis by downregulating the expression of VEGFR3 and PROX1 in human lymphatic endothelial cells
- (2016) Yazong Yang et al. Oncotarget
- Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3
- (2016) Dror Alishekevitz et al. Cell Reports
- VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study
- (2015) Mikko T. Visuri et al. ANGIOGENESIS
- Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications
- (2015) Amit Walia et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 “multi-points priming” mechanisms in vitro and in vivo
- (2015) Xin-Ping Li et al. BMC CANCER
- Simultaneousin vivoimaging of blood and lymphatic vessel growth in Prox1-GFP/Flk1::myr-mCherry mice
- (2015) Jimmy Zhu et al. FEBS Journal
- Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection
- (2015) Ye Cui et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase III Trial Evaluating the Addition of Bevacizumab to Endocrine Therapy As First-Line Treatment for Advanced Breast Cancer: The Letrozole/Fulvestrant and Avastin (LEA) Study
- (2015) Miguel Martín et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor
- (2015) Y. Zhao et al. ONCOLOGIST
- The lymph node microenvironment and its role in the progression of metastatic cancer
- (2015) Ethel R. Pereira et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- The role of the lymphatic system in inflammatory-erosive arthritis
- (2015) Echoe M. Bouta et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Anti-EGFR Antibody Reduces Lung Nodules by Inhibition of EGFR-Pathway in a Model of Lymphangioleiomyomatosis
- (2015) Elena Lesma et al. Biomed Research International
- Blockade of VEGF-C and VEGF-D modulates adipose tissue inflammation and improves metabolic parameters under high-fat diet
- (2015) Sinem Karaman et al. Molecular Metabolism
- EGFR Regulates the Development and Microarchitecture of Intratumoral Angiogenic Vasculature Capable of Sustaining Cancer Cell Intravasation
- (2015) Petra Minder et al. NEOPLASIA
- Vascular Endothelial Growth Factor Receptor 3 Signaling Contributes to Angioobliterative Pulmonary Hypertension
- (2015) Ayser Al-Husseini et al. Pulmonary Circulation
- NSK-01105, a Novel Sorafenib Derivative, Inhibits Human Prostate Tumor Growth via Suppression of VEGFR2/EGFR-Mediated Angiogenesis
- (2015) Pengfei Yu et al. PLoS One
- Th2 Cytokines Inhibit Lymphangiogenesis
- (2015) Ira L. Savetsky et al. PLoS One
- Improved Angiogenesis in Response to Localized Delivery of Macrophage-Recruiting Molecules
- (2015) Chih-Wei Hsu et al. PLoS One
- ADAM17 Promotes Motility, Invasion, and Sprouting of Lymphatic Endothelial Cells
- (2015) Renata Mężyk-Kopeć et al. PLoS One
- The connection between lymphangiogenic signalling and prostaglandin biology: A missing link in the metastatic pathway
- (2015) Tara Karnezis et al. Oncotarget
- Phosphorylated Epidermal Growth Factor Receptor on Tumor-Associated Endothelial Cells Is a Primary Target for Therapy with Tyrosine Kinase Inhibitors
- (2015) Toshio Kuwai et al. NEOPLASIA
- Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
- (2014) Naveen S. Vasudev et al. ANGIOGENESIS
- Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression
- (2014) Heyan Li et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Inhibition of Lymphangiogenesis of Endothelial Progenitor Cells with VEGFR-3 siRNA Delivered with PEI-alginate Nanoparticles
- (2014) Ting Li et al. International Journal of Biological Sciences
- Efficacy and safety of angiogenesis inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis
- (2014) Shaodong Hong et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Mechanisms of lymphatic metastasis
- (2014) Sinem Karaman et al. JOURNAL OF CLINICAL INVESTIGATION
- Emerging roles of lymphatic endothelium in regulating adaptive immunity
- (2014) Catherine M. Card et al. JOURNAL OF CLINICAL INVESTIGATION
- Inflammation-associated lymphangiogenesis: a double-edged sword?
- (2014) Honsoul Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial
- (2014) Gunter von Minckwitz et al. LANCET ONCOLOGY
- Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial
- (2014) Joseph Gligorov et al. LANCET ONCOLOGY
- Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib
- (2014) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling
- (2014) Hong Ji et al. Nature Communications
- Immunomodulatory Roles of Lymphatic Vessels in Cancer Progression
- (2014) M. A. Swartz Cancer Immunology Research
- Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
- (2014) Vladimir Riabov et al. Frontiers in Physiology
- Lymphatic vessels: new targets for the treatment of inflammatory diseases
- (2013) Lothar C. Dieterich et al. ANGIOGENESIS
- Endostar Combined with Cisplatin Inhibits Tumor Growth and Lymphatic Metastasis of Lewis Lung Carcinoma Xenografts in Mice
- (2013) Xiao-Peng Dong et al. Asian Pacific Journal of Cancer Prevention
- Mechanisms of resistance to anti-angiogenesis therapies
- (2013) Sandy Giuliano et al. BIOCHIMIE
- VEGF-C and VEGF-D Blockade Inhibits Inflammatory Skin Carcinogenesis
- (2013) A. K. Alitalo et al. CANCER RESEARCH
- Feasibility of MR imaging in evaluating breast cancer lymphangiogenesis using Polyethylene glycol-GoldMag nanoparticles
- (2013) H. Yang et al. CLINICAL RADIOLOGY
- Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer
- (2013) Jonathan Welti et al. JOURNAL OF CLINICAL INVESTIGATION
- AVEREL: A Randomized Phase III Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER2-Positive Locally Recurrent/Metastatic Breast Cancer
- (2013) Luca Gianni et al. JOURNAL OF CLINICAL ONCOLOGY
- Activation of the epidermal growth factor receptor promotes lymphangiogenesis in the skin
- (2013) Daniela Marino et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Lymphatic Endothelial Differentiation in Pulmonary Lymphangioleiomyomatosis Cells
- (2013) Jennifer M. Davis et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis
- (2013) Tracey DiSipio et al. LANCET ONCOLOGY
- The quest to overcome resistance to EGFR-targeted therapies in cancer
- (2013) Curtis R Chong et al. NATURE MEDICINE
- Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
- (2013) Lenny van Bon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lymphedema and Therapeutic Lymphangiogenesis
- (2013) Yukihiro Saito et al. Biomed Research International
- Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration
- (2012) Inho Choi et al. ANGIOGENESIS
- Evidence for the interaction of fibroblast growth factor-2 with the lymphatic endothelial cell marker LYVE-1
- (2012) N. Platonova et al. BLOOD
- Landscape of EGFR signaling network in human cancers: Biology and therapeutic response in relation to receptor subcellular locations
- (2012) Woody Han et al. CANCER LETTERS
- Anti-angiogenesis therapy in cancer: Current challenges and future perspectives
- (2012) Farbod Shojaei CANCER LETTERS
- Tumor vasculature: the Achilles' heel of cancer?
- (2012) Tor-Christian Aase Johannessen et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema
- (2012) Tomer Avraham et al. FASEB JOURNAL
- Lymphangioleiomyomatosis — a wolf in sheep’s clothing
- (2012) Elizabeth P. Henske et al. JOURNAL OF CLINICAL INVESTIGATION
- Epidermal Growth Factor Facilitates Melanoma Lymph Node Metastasis by Influencing Tumor Lymphangiogenesis
- (2012) Andreas Bracher et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Mammary cancer gene therapy targeting lymphangiogenesis: VEGF-C siRNA and soluble VEGF receptor-2, a splicing variant
- (2012) Masa-Aki Shibata et al. Medical Molecular Morphology
- Tumor-Derived Microvesicles Induce Proangiogenic Phenotype in Endothelial Cells via Endocytosis
- (2012) Taisuke Kawamoto et al. PLoS One
- Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis
- (2012) R. Cao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- VEGF-C Promotes Immune Tolerance in B16 Melanomas and Cross-Presentation of Tumor Antigen by Lymph Node Lymphatics
- (2012) Amanda W. Lund et al. Cell Reports
- Present and Future of EGFR Inhibitors for Head and Neck Squamous Cell Cancer
- (2012) Yuh Baba et al. Journal of Oncology
- Tumor Lymphangiogenesis as a Potential Therapeutic Target
- (2012) Tam Duong et al. Journal of Oncology
- Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease
- (2011) J.-F. Rahier et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Blockade of Prolymphangiogenic Vascular Endothelial Growth Factor C in Dry Eye Disease
- (2011) Sunali Goyal ARCHIVES OF OPHTHALMOLOGY
- RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
- (2011) Adam M. Brufsky et al. JOURNAL OF CLINICAL ONCOLOGY
- RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
- (2011) Nicholas J. Robert et al. JOURNAL OF CLINICAL ONCOLOGY
- The lymphatic vasculature in disease
- (2011) Kari Alitalo NATURE MEDICINE
- Antiangiogenic therapy, hypoxia and metastasis: risky liaisons, or not?
- (2011) Katrien De Bock et al. Nature Reviews Clinical Oncology
- Evidence of Corneal Lymphangiogenesis in Dry Eye Disease
- (2010) Sunali Goyal ARCHIVES OF OPHTHALMOLOGY
- Lymphangiogenesis: Molecular Mechanisms and Future Promise
- (2010) Tuomas Tammela et al. CELL
- Cold shock domain protein A (CSDA) overexpression inhibits tumor growth and lymph node metastasis in a mouse model of squamous cell carcinoma
- (2010) Goichi Matsumoto et al. CLINICAL & EXPERIMENTAL METASTASIS
- Epidermal growth factor receptor targeted therapy in stage III and IV head and neck cancer
- (2010) C. Cripps et al. Current Oncology
- Quantitative lymphatic vessel trait analysis suggests Vcam1 as candidate modifier gene of inflammatory bowel disease
- (2010) G Jurisic et al. GENES AND IMMUNITY
- Deguelin-An inhibitor to tumor lymphangiogenesis and lymphatic metastasis by downregulation of vascular endothelial cell growth factor-D in lung tumor model
- (2010) Jia Hu et al. INTERNATIONAL JOURNAL OF CANCER
- Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
- (2010) David W. Miles et al. JOURNAL OF CLINICAL ONCOLOGY
- ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective
- (2010) Ruchi Saxena et al. MEDICINAL RESEARCH REVIEWS
- Immune Privilege of Corneal Allografts
- (2010) Jerry Y. Niederkorn et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Lymphangiogenesis: A new player in cancer progression
- (2010) Masayuki Nagahashi WORLD JOURNAL OF GASTROENTEROLOGY
- Immunohistochemical expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis
- (2010) Seta A Sarkis et al. Head and Neck Optical Diagnostics Society
- Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
- (2009) Kristy J. Gotink et al. ANGIOGENESIS
- Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
- (2009) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis
- (2009) Ruolin Guo et al. ARTHRITIS AND RHEUMATISM
- Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model
- (2009) M Yashiro et al. BRITISH JOURNAL OF CANCER
- Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited
- (2009) Sonja Loges et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance
- (2009) G. N. Naumov et al. CLINICAL CANCER RESEARCH
- Hypoxia-inducible factor in cancer angiogenesis: Structure, regulation and clinical perspectives
- (2009) Zaher K. Otrock et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Independent Review of E2100: A Phase III Trial of Bevacizumab Plus Paclitaxel Versus Paclitaxel in Women With Metastatic Breast Cancer
- (2009) Robert Gray et al. JOURNAL OF CLINICAL ONCOLOGY
- Cutting Edge: Lymphatic Vessels, Not Blood Vessels, Primarily Mediate Immune Rejections After Transplantation
- (2009) T. Dietrich et al. JOURNAL OF IMMUNOLOGY
- Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR
- (2009) K. Al-Nedawi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo
- (2008) X-w He et al. CANCER GENE THERAPY
- EGFR family: Structure physiology signalling and therapeutic targets†
- (2008) Antony W. Burgess GROWTH FACTORS
- Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model
- (2008) Jing Wen et al. INTERNATIONAL JOURNAL OF CANCER
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started